Xyrem (sodium Oxybate) Prior Approval Criteria
Definition: Xyrem (sodium oxybate) is a central nervous system depressant that reduces excessive daytime sleepiness and cataplexy in patients with narcolepsy. Sodium oxybate is intended for oral administration. Sodium oxybate is GHB, a known drug of abuse. ... Doc Retrieval
Medications For Treating Daytime Sleepiness In Narcolepsy
Medications for Treating Daytime Sleepiness in Narcolepsy Note: mg = milligrams. sodium oxybate Xyrem 2.5 to 4.5 grams at bedtime and repeated 3 to 4 hours later morning sedation, nausea, dizziness, urinary incontinence, sleepwalking ... Access Doc
Therapeutic Class Overview Narcolepsy Agents (non-stimulant)
Daytime sleepiness (EDS) and intermittent, uncontrollable episodes of falling asleep during the daytime. 4: It is important to note that EDS is distinct from fatigue. Generally, fatigue is a subjective feeling of lack of The Xyrem ® Success Program ... Access This Document
Fibromyalgia Drugs - About.com Health
Doctors prescribe a lot of different fibromyalgia drugs. See what kinds of drugsthey are, how they work, and excessive daytime sleepiness in patients with narcolepsy. Note: Because of its potential for abuse, Xyrem is a Schedule III federally controlled substance. ... Read Article
Xyrem (Medicare Prior Authorization)
Xyrem (Medicare Prior Authorization) This fax machine is located in a secure location as required by HIPAA regulations. Does the patient experience excessive daytime sleepiness with symptoms that limit the ability to perform normal daily activities? Y N . Comments: ... Retrieve Content
Treating Sleep Disorders
General information about how sleep disorders are treated, including how to get the most out of your encounter with your doctor, treatment options (medicines, machines, lifestyle changes, and alternatives), risks and limitations, and new treatments and recent advances in therapy. ... Read Article
XYREM (sodium Oxybate) PRIOR AUTHORIZATION CRITERIA
Xyrem (sodium oxybate) is a central nervous system depressant that has been shown in clinical studies to reduce excessive daytime sleepiness and cataplexy in patients with narcolepsy. ... Retrieve Full Source
Xyrem (sodium Oxybate) Prior Authorization And Quantity Limit ...
Daytime sleepiness. Xyrem will not be covered for patients with a listed contraindication: patient is using a sedative hypnotic agent concurrently or patient has succinic semialdehyde dehydrogenase deficiency. Patients receiving Xyrem must be enrolled in the Xyrem Success ... Get Document
ORIGINAL CONTRIBUTION Sodium Oxybate For Excessive Daytime ...
Sodium Oxybate for Excessive Daytime Sleepiness in Parkinson Disease An Open-Label Polysomnographic Study William G. Ondo, MD; Thomas Perkins, MD; Todd Swick, MD; Sodium oxybate (Xyrem; Jazz Pharmaceuticals, Inc) isauniquecompoundapprovedbytheUSFoodandDrug ... Content Retrieval
Does Narcolepsy Go Away - Sleep Disorders
Question: Does Narcolepsy Go Away? Answer: Narcolepsy can be a difficult condition to live with, with debilitating excessive daytime sleepiness and cataplexy, so it is natural to wonder about the long-term prognosis. ... Read Article
(sodium Oxybate) Oral Solution - Food And Drug Administration
Xyrem® (sodium oxybate) oral solution CIII!WARNING: Central nervous system depressant daytime sleepiness in narcolepsy was established in two randomized, double-blind, placebo-controlled trials (Trials 3 and 4) in patients with narcolepsy. ... Fetch Content
Excessive daytime sleepiness - Wikipedia, The Free Encyclopedia
Excessive daytime sleepiness (EDS) is characterized by persistent sleepiness and often a general lack of energy, even during the day after apparently adequate or even prolonged nighttime sleep. ... Read Article
Prior Authorization Criteria P&T Reviewed: 12/05, 6/07, 6/08 ...
Excessive Daytime Sleepiness associated with Narcolepsy (all below criteria must be met) Patient must be older than 16. Xyrem® [package insert]. Jazz Pharmaceuticals, Inc., Palo Alto, CA. Title: Microsoft Word - xyrem.doc Author: ... Document Viewer
Sodium Oxybate For Excessive Daytime Sleepiness In Parkinson ...
Sodium Oxybate for Excessive Daytime Sleepiness in Parkinson’s Disease: A Polysomnographic Study William Ondo, MD1, Thomas Perkins, Sodium Oxybate (Xyrem®, Jazz Pharmaceuticals) is a unique compound approved to treat both cataplexy and ... Document Retrieval
Xyrem, INN - Sodium Oxybate - European Medicines Agency
The other two studies (516 patients) examined the effects of Xyrem on excessive daytime sleepiness and other symptoms of narcolepsy, either taken alone or as an add-on to the patient’s existing dose of modafinil (a stimulant medicine used to treat narcolepsy). ... Fetch Document
SODIUM OXYBATE (Xyrem UTILIZATION MANAGEMENT CRITERIA
SODIUM OXYBATE (Xyrem FDA-APPROVED INDICATIONS Treatment of excessive daytime sleepiness and cataplexy in patients with narcolepsy. COVERAGE AUTHORIZATION CRITERIA Sodium oxybate (Xyrem) is covered for the following condition: ... Doc Retrieval
Xyrem (sodium Oxybate) - Martinspoint.org
• Xyrem is being used for the treatment of excessive daytime sleepiness and cataplexy in a patient with narcolepsy. • Narcolepsy was diagnosed by polysomnogram or mean sleep latency time (MSLT) objective testing. ... View Full Source
Talk:Excessive daytime sleepiness - Wikipedia, The Free ...
I believe the correct medical term is "Excessive daytime somnolence". Consider having "Excessive daytime sleepiness" redirect there instead of vice versa. ... Read Article
Xyrem® (sodium Oxybate) Oral Solution CIII
Xyrem is a prescription medicine used to treat the following symptoms in people who fall asleep frequently during the day, often at unexpected times (narcolepsy): ... View Document
Sodium Oxybate - Wikipedia, The Free Encyclopedia
Sodium oxybate (brand names Xyrem, Alcover, Anetamin, Gamanest, Gioron, Somsanit), contracted from sodium γ-hydroxybutyrate, is a prescription medication approved by the U.S. Food and Drug Administration (FDA) for the treatment of excessive daytime sleepiness (EDS) associated with narcolepsy ... Read Article
Prior Authorization Criteria For Xyrem (sodium Oxybate)
Prior Authorization Criteria for Xyrem (sodium oxybate) Background . Sodium oxybate (Xyrem) is approved by the FDA for the treatment of excessive daytime sleepiness and ... Document Retrieval
Prior Authorization Criteria Form - Aetna
Prior Authorization Form Xyrem This fax machine is located in a secure location as required by HIPAA regulations. Complete/review information, sign and date. ... View Document
Excessive Daytime Sleepiness: Julie Flygare Narcolepsy ...
An interview with Julie Flygare from the 2012 Narcolepsy Network Conference in Cleveland, OH. Describes her experience presenting three sessions at the conference. Gives a few tips for communicating about the Excessive Daytime Sleepiness (EDS) symptom of narcolepsy. (Watch in 1080p HD ... View Video
A Pilot Study On The Effects Of Sodium Oxybate On Sleep ...
Daytime Sleepiness Increased 12 (57) 1 (5) 1(5) 0 (0) 0 (0) Borgen L, Lane E, Lai A. Xyrem ® (sodium oxybate): a study of dose proportionality in healthy human subjects. J Clin Pharmacol 2000;40:1053. 16. Mamelak M, Escriu JM, Stokan O. ... Doc Retrieval
Xyrem (sodium Oxybate) - SummaCare
XYREM (MEDICARE ONLY the SummaCare commercial prescription benefits, refer to “SummaCare Xyrem PA Criteria – Commercial” Coverage of Xyrem® will ® Patient Success Program. AND 2. The patient has a confirmed diagnosis of narcolepsy with cataplexy or excessive daytime sleepiness. ... Visit Document